[ad_1] Clinical-stage biotechnology company Arvinas (NASDAQ:ARVN) appointed Noah Berkowitz, M.D., Ph.D., to the role of chief medical officer and a member of the…
Browsing: Arvinas
[ad_1] Arvinas, Inc., a biopharmaceutical company specializing in protein degradation-based treatments, has announced the successful arrangement of a private placement…
[ad_1] Risk Disclosure: Fusion Media will not accept any liability for loss or damage as a result of reliance on…
[ad_1] koto_feja Arvinas, Inc (NASDAQ:ARVN) announced Tuesday early results from its Phase 2 cohort expansion portion of a Phase 1/2…